Literature DB >> 22736223

Connexin 43 interacts with Bax to regulate apoptosis of pancreatic cancer through a gap junction-independent pathway.

Yan Sun1, Xiaoping Zhao, Yuting Yao, Xinyi Qi, Yaozong Yuan, Yu Hu.   

Abstract

Connexins play important roles in many physiological and pathological processes. Although connexins are considered as tumor suppressors in several types of cancer, their roles in pancreatic cancer are unknown. In this study, we found that connexin 43 (Cx43) caused apparent apoptosis and growth inhibition in pancreatic cancer cells. The tumor-suppressive role of Cx43 was independent of the canonical gap junction pathway. In the context of apoptosis, Cx43 translocated to the mitochondria, where it interacted with Bax to initiate the mitochondrial apoptotic pathway. Following further examination of the Cx43 protein, we found that the 241-382aa region of Cx43 was required for interaction with Bax. Furthermore, this region was responsible for permeabilizing mitochondrial membrane potential. The results from the present study elucidate a novel mechanism of the Cx43-mediated regulation of apoptosis in pancreatic cancer.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22736223     DOI: 10.3892/ijo.2012.1524

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  23 in total

1.  SREBP1 regulates tumorigenesis and prognosis of pancreatic cancer through targeting lipid metabolism.

Authors:  Yan Sun; Weiwei He; Man Luo; Yuhong Zhou; Guilin Chang; Weiying Ren; Kefen Wu; Xi Li; Jiping Shen; Xiaoping Zhao; Yu Hu
Journal:  Tumour Biol       Date:  2015-01-15

Review 2.  Connexins in the Heart: Regulation, Function and Involvement in Cardiac Disease.

Authors:  Antonio Rodríguez-Sinovas; Jose Antonio Sánchez; Laura Valls-Lacalle; Marta Consegal; Ignacio Ferreira-González
Journal:  Int J Mol Sci       Date:  2021-04-23       Impact factor: 5.923

Review 3.  Therapeutic strategies targeting connexins.

Authors:  Dale W Laird; Paul D Lampe
Journal:  Nat Rev Drug Discov       Date:  2018-10-12       Impact factor: 84.694

Review 4.  Connexin 43 is an emerging therapeutic target in ischemia/reperfusion injury, cardioprotection and neuroprotection.

Authors:  Rainer Schulz; Philipp Maximilian Görge; Anikó Görbe; Péter Ferdinandy; Paul D Lampe; Luc Leybaert
Journal:  Pharmacol Ther       Date:  2015-06-11       Impact factor: 12.310

5.  Mitochondrial connexin40 regulates mitochondrial calcium uptake in coronary endothelial cells.

Authors:  Rui Guo; Rui Si; Brian T Scott; Ayako Makino
Journal:  Am J Physiol Cell Physiol       Date:  2017-01-25       Impact factor: 4.249

Review 6.  Gap junctions and cancer: communicating for 50 years.

Authors:  Trond Aasen; Marc Mesnil; Christian C Naus; Paul D Lampe; Dale W Laird
Journal:  Nat Rev Cancer       Date:  2016-10-21       Impact factor: 60.716

7.  Modulation of gap junction-associated Cx43 in neural stem/progenitor cells following traumatic brain injury.

Authors:  Kisha Greer; Jiang Chen; Thomas Brickler; Robert Gourdie; Michelle H Theus
Journal:  Brain Res Bull       Date:  2017-06-23       Impact factor: 4.077

Review 8.  Gap junction and hemichannel-independent actions of connexins on cell and tissue functions--an update.

Authors:  Jade Z Zhou; Jean X Jiang
Journal:  FEBS Lett       Date:  2014-01-14       Impact factor: 4.124

9.  Connexin 26 is down-regulated by KDM5B in the progression of bladder cancer.

Authors:  Xin Li; Yongping Su; Jinhong Pan; Zhansong Zhou; Bo Song; Enqing Xiong; Zhiwen Chen
Journal:  Int J Mol Sci       Date:  2013-04-11       Impact factor: 5.923

Review 10.  The role of connexins in breast cancer: from misregulated cell communication to aberrant intracellular signaling.

Authors:  Yagmur Ceren Unal; Busra Yavuz; Engin Ozcivici; Gulistan Mese
Journal:  Tissue Barriers       Date:  2021-08-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.